comparative effectiveness

Research in Review

Financial Burden of ACPA Status in Patients With Rheumatoid Arthritis

08/15/2017

JCP Editors

A recent comparative effectiveness study examined the relationship of anticitrullinated protein antibody (ACPA) status and accrued economic burden for patients with rheumatoid arthritis, published in the Journal of...

A...

08/15/2017

Journal of Clinical Pathways

Research in Review

Impact of Vitamin D Deficiency on Relapse in Patients With Myeloid Malignancies

08/10/2017

JCP Editors

Patients with myeloid malignancies who have vitamin D deficiency before undergoing allogeneic stem cell transplantation (alloSCT) are at a higher risk of relapse, according to recent research published in the Journal...

...

08/10/2017

Journal of Clinical Pathways

Research in Review

Double Dosage of ALK Inhibitor Improves Outcomes in NSCLC

08/09/2017

JCP Editors

Increasing the standard dose of an anaplastic lymphoma kinase (ALK) inhibitor for the treatment of non-small cell lung cancer (NSCLC) improves objective response rates (ORR) by 9% with limited additional toxicity,...

...

08/09/2017

Journal of Clinical Pathways

Research in Review

Comparative Effectiveness Study Identifies Optimal Therapy for MCL

08/02/2017

JCP Editors

A recent study showed improved long-term survival outcomes and quality of life (QoL) for patients with mantle cell lymphoma (MCL) receiving tyrosine kinase inhibitor (TKI) therapy compared with those receiving...

A...

08/02/2017

Journal of Clinical Pathways

Research in Review

Optimal Therapy for Type of B-Cell Malignancy

08/02/2017

JCP Editors

A...

08/02/2017

Journal of Clinical Pathways

Research in Review

Older Patients With Advanced-Stage Rectal Cancer Often Receive Sub-Optimal Treatment

08/01/2017

JCP Editors

A majority of older patients with stage II or III rectal adenocarcinoma do not receive standard-of-care treatment, according to recent research published in Cancer (online July 31, 2017;...

A...

08/01/2017

Journal of Clinical Pathways

Research in Review

CLL Long-Term Survival Likely to Improve With Novel Therapies

07/26/2017

JCP Editors

Novel agents are predicted to significantly improve lifetime overall survival (OS) and quality-adjusted life-years (QALYs) compared with traditional therapies for patients with chronic lymphocytic leukemia (CLL),...

Novel...

07/26/2017

Journal of Clinical Pathways

Research in Review

Is Active Surveillance Beneficial for Patients With Intermediate-Risk Prostate Cancer?

07/20/2017

JCP Editors

Recent research explored the potential of a subset of patients with intermediate-risk prostate cancer likely to benefit from active surveillance. Active surveillance is currently recommended for patients with...

Recent...

07/20/2017

Journal of Clinical Pathways

Research in Review

CAR-T Therapy Response Independent of Disease Factors in NHL

07/10/2017

JCP Editors

A recent clinical trial of a chimeric antigen receptor (CAR) T-cell therapy showed a significantly high response rate in treatment-resistant and relapsed aggressive non-Hodgkin lymphoma (NHL) independent of disease...

A...

07/10/2017

Journal of Clinical Pathways

Research in Review

Does Intensified Therapy Improve Prognosis in DLBCL?

07/03/2017

JCP Editors

Recent research compared the effects of standard chemotherapy dosage with intensified chemotherapy for patients with high-risk diffuse large B-cell lymphoma (DLBCL), published in The Lancet Oncology (published online...

Recent...

07/03/2017

Journal of Clinical Pathways